NDC 59651-533 – Eslicarbazepine Acetate
Eslicarbazepine Acetate 200 mg/1 · Tablet · Oral
Product NDC59651-533
Product details
- Brand name
- Eslicarbazepine Acetate
- Generic name
- Eslicarbazepine Acetate
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA216481
- Marketed since
- August 5, 2026
- Listing expires
- December 31, 2027
Active ingredients
- Eslicarbazepine Acetate 200 mg/1
Uses, dosage, side effects and warnings for Eslicarbazepine acetate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 59651-533-30 | 30 TABLET in 1 BOTTLE (59651-533-30) | Aug 5, 2026 |
Other Eslicarbazepine acetate products
- 60505-4658 Eslicarbazepine Acetate 200 mg/1 · Tablet · Apotex Corp.
- 60505-4660 Eslicarbazepine Acetate 600 mg/1 · Tablet · Apotex Corp.
- 60505-4661 Eslicarbazepine Acetate 800 mg/1 · Tablet · Apotex Corp.
- 60505-4659 Eslicarbazepine Acetate 400 mg/1 · Tablet · Apotex Corp.
- 67877-588 Eslicarbazepine Acetate 800 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-587 Eslicarbazepine Acetate 600 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-585 Eslicarbazepine Acetate 200 mg/1 · Tablet · Ascend Laboratories, LLC
- 67877-586 Eslicarbazepine Acetate 400 mg/1 · Tablet · Ascend Laboratories, LLC
- 59651-534 Eslicarbazepine Acetate 400 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-535 Eslicarbazepine Acetate 600 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-536 Eslicarbazepine Acetate 800 mg/1 · Tablet · Aurobindo Pharma Limited
- 31722-430 Eslicarbazepine Acetate 600 mg/1 · Tablet · Camber Pharmaceuticals, Inc.